Search research articles
Contact Us
Filters
Showing results (51-60 of 224) with videos related to
Page
of 23
Sort By:
Cancer Chemotherapy and Pharmacology
|
March 21, 2020
SNPs in the COX-2/PGES/EP signaling pathway are associated with risk of severe capecitabine-induced hand-foot syndrome
Xin Liao, Liu Huang, Qianqian Yu, et al.
International Journal of Medical Sciences
|
January 9, 2023
Artificial intelligence in clinical decision support systems for oncology
Lu Wang, Xinyi Chen, Lu Zhang, et al.
Journal of Gastrointestinal Oncology
|
May 13, 2022
Efficacy and safety of low-dose apatinib plus S-1 versus regorafenib and fruquintinib for refractory metastatic colorectal cancer: a retrospective cohort study
Yuhong Dai, Li Sun, Liang Zhuang, et al.
Cancer Medicine
|
February 18, 2017
Genetic variants in the plasminogen activator inhibitor-1 gene are associated with an increased risk of radiation pneumonitis in lung cancer patients
Bo Liu, Yang Tang, Minxiao Yi, et al.
International Journal of Biological Sciences
|
September 23, 2024
RUNX1-MUC13 Interaction Activates Wnt/β-Catenin Signaling Implications for Colorectal Cancer Metastasis
Xinyi Chen, Jingyao Tu, Mu Yang, et al.
Frontiers in Immunology
|
June 19, 2023
The application and research progress of anti-angiogenesis therapy in tumor immunotherapy
Jingyao Tu, Hang Liang, Chunya Li, et al.
Journal of Nanobiotechnology
|
June 13, 2026
An inhalable nanozyme for STING blockade to treat radiation-induced lung injury
Yongbiao Huang, Min Luo, Zhirong Bao, et al.
Digital Health
|
July 9, 2026
Interpretable early mortality prediction in oncology ICU patients: A dual-cohort validation of a LASSO-XGBoost-SHAP framework
Xinyi Chen, Lu Wang, Wan Qin, et al.
Translational Oncology
|
July 10, 2026
CXCL11 recruits immunosuppressive cells to form a barrier at the invasive front of pancreatic cancer by activating the NF-κB/CCL2 axis
Fang Wei, Lu Yang, Xianghai Zeng, et al.
Bioengineered
|
February 10, 2022
Cilengitide, an αvβ3-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model
Xin Pan, Minxiao Yi, Chaofan Liu, et al.
Page
of 23
Search research articles
Search
Showing results (51-60 of 224) with videos related to
Sort By:
Page
of 23
Cancer Chemotherapy and Pharmacology
|
March 21, 2020
SNPs in the COX-2/PGES/EP signaling pathway are associated with risk of severe capecitabine-induced hand-foot syndrome
Xin Liao, Liu Huang, Qianqian Yu, et al.
International Journal of Medical Sciences
|
January 9, 2023
Artificial intelligence in clinical decision support systems for oncology
Lu Wang, Xinyi Chen, Lu Zhang, et al.
Journal of Gastrointestinal Oncology
|
May 13, 2022
Efficacy and safety of low-dose apatinib plus S-1 versus regorafenib and fruquintinib for refractory metastatic colorectal cancer: a retrospective cohort study
Yuhong Dai, Li Sun, Liang Zhuang, et al.
Cancer Medicine
|
February 18, 2017
Genetic variants in the plasminogen activator inhibitor-1 gene are associated with an increased risk of radiation pneumonitis in lung cancer patients
Bo Liu, Yang Tang, Minxiao Yi, et al.
International Journal of Biological Sciences
|
September 23, 2024
RUNX1-MUC13 Interaction Activates Wnt/β-Catenin Signaling Implications for Colorectal Cancer Metastasis
Xinyi Chen, Jingyao Tu, Mu Yang, et al.
Frontiers in Immunology
|
June 19, 2023
The application and research progress of anti-angiogenesis therapy in tumor immunotherapy
Jingyao Tu, Hang Liang, Chunya Li, et al.
Journal of Nanobiotechnology
|
June 13, 2026
An inhalable nanozyme for STING blockade to treat radiation-induced lung injury
Yongbiao Huang, Min Luo, Zhirong Bao, et al.
Digital Health
|
July 9, 2026
Interpretable early mortality prediction in oncology ICU patients: A dual-cohort validation of a LASSO-XGBoost-SHAP framework
Xinyi Chen, Lu Wang, Wan Qin, et al.
Translational Oncology
|
July 10, 2026
CXCL11 recruits immunosuppressive cells to form a barrier at the invasive front of pancreatic cancer by activating the NF-κB/CCL2 axis
Fang Wei, Lu Yang, Xianghai Zeng, et al.
Bioengineered
|
February 10, 2022
Cilengitide, an αvβ3-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model
Xin Pan, Minxiao Yi, Chaofan Liu, et al.
Page
of 23